Randomized Trial of Prolonged Exposure for the Treatment of Posttraumatic Stress Disorder (PTSD)
Last updated on April 2022Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 100
Inclusion Criteria
- 18 to < 65 years
- Meet diagnostic criteria for PTSD
- Spanish speaker
- ...
- 18 to < 65 years
- Meet diagnostic criteria for PTSD
- Spanish speaker
- Allow recording of assessments and therapy
Exclusion Criteria
- History of bipolar, schizophrenia or psychotic disorder
- Significant current suicidal or homicidal ideation
- Current psychotherapy to treat PTSD
- ...
- History of bipolar, schizophrenia or psychotic disorder
- Significant current suicidal or homicidal ideation
- Current psychotherapy to treat PTSD
- Current high risk of being assaulted (i.e., living with domestic violence)
- Alcohol or drug abuse during the past three months
- Unable to provide informed consent
Summary
- Conditions
- Posttraumatic Stress Disorder
- Type
- Interventional
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 64 years
- Gender
- Both males and females
Inclusion Criteria
- 18 to < 65 years
- Meet diagnostic criteria for PTSD
- Spanish speaker
- ...
- 18 to < 65 years
- Meet diagnostic criteria for PTSD
- Spanish speaker
- Allow recording of assessments and therapy
Exclusion Criteria
- History of bipolar, schizophrenia or psychotic disorder
- Significant current suicidal or homicidal ideation
- Current psychotherapy to treat PTSD
- ...
- History of bipolar, schizophrenia or psychotic disorder
- Significant current suicidal or homicidal ideation
- Current psychotherapy to treat PTSD
- Current high risk of being assaulted (i.e., living with domestic violence)
- Alcohol or drug abuse during the past three months
- Unable to provide informed consent
Tracking Information
- NCT #
- NCT02134691
- Collaborators
- National Institute of Mental Health (NIMH)
- Investigators
- Principal Investigator: Mildred Vera, Ph.D University of Puerto Rico Medical Sciences Campus
- Mildred Vera, Ph.D University of Puerto Rico Medical Sciences Campus